CN102091217A - Traditional Chinese medicinal composition for treating hyperplasia of mammary glands - Google Patents
Traditional Chinese medicinal composition for treating hyperplasia of mammary glands Download PDFInfo
- Publication number
- CN102091217A CN102091217A CN2009102194693A CN200910219469A CN102091217A CN 102091217 A CN102091217 A CN 102091217A CN 2009102194693 A CN2009102194693 A CN 2009102194693A CN 200910219469 A CN200910219469 A CN 200910219469A CN 102091217 A CN102091217 A CN 102091217A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- traditional chinese
- chinese medicinal
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to the technical field of traditional Chinese medicaments, in particular to a traditional Chinese medicinal composition for treating hyperplasia of mammary glands. The traditional Chinese medicinal composition for treating the hyperplasia of mammary glands solves the problems of slow response and undesirable curative effect in the prior art. The traditional Chinese medicinal composition for treating the hyperplasia of mammary glands consists of the following ingredients in part by weight: 80 parts of bupleurum, 80 parts of white paeony root, 63 parts of nutgrass galingale rhizome, 100 parts of selfheal, 85 parts of oyster, 85 parts of root of red-rooted salvia, 22 parts of scorpion, 68 parts of scutellaria laterifolia, 70 parts of centipede, 4 parts of borneol, 110 parts of pseudo-ginseng, 18 parts of chicken's gizzardskin, 15 parts of frankincense, 15 parts of largehead atractylodes rhizome, 28 parts of myrrh, 102 parts of bittersweet herb, 50 parts of spreading hedyotis herb, 75 parts of asparagus and 60 parts of astragalus. The traditional Chinese medicinal composition for treating the hyperplasia of mammary glands has the advantages of: 1, good curative effect; 2, pure traditional Chinese medicinal preparation, safety and reliability; and 3, low cost and easiness in popularization and application.
Description
Technical field:
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of cyclomastopathy.
Background technology:
Cyclomastopathy is a kind of frequently-occurring disease, the common generation of middle aged and aged women.The Chinese herb medicine of having seen at present the treatment cyclomastopathy is a lot, but has certain defective: slow as curative effect, therapeutic effect is undesirable etc.
Summary of the invention:
The present invention will provide a kind of Chinese medicine composition for the treatment of cyclomastopathy, and is slow to overcome the curative effect that prior art exists, the unfavorable problem of therapeutic effect.
For overcoming the problem that prior art exists, technical scheme of the present invention is: a kind of Chinese medicine composition for the treatment of cyclomastopathy, form by following component: 75～95 parts of Radix Bupleuri, 75～95 parts of the Radix Paeoniae Albas, 55～70 parts of Rhizoma Cyperis, 90～120 parts of Spica Prunellaes, 75～95 parts of Concha Ostreaes, 75～95 parts of Radix Salviae Miltiorrhizaes, 18～25 parts of Scorpios, 60～75 parts of Radix Scutellariae, 60～80 parts of Scolopendras, 3～5 parts of Borneolum Syntheticums, 100～120 parts of Radix Notoginseng, 15～20 parts of Endothelium Corneum Gigeriae Galli, 12～18 parts of Olibanums, 12～18 parts of the Rhizoma Atractylodis Macrocephalaes, 25～32 parts of Myrrhas, 95～110 parts of Herba Solani Lyratis, 50～60 parts of Herba Hedyotidis Diffusaes, 40～75 parts of Radix Asparagis, 60～100 parts of the Radixs Astragali.
The best of above-mentioned component is formed: 80 parts of Radix Bupleuri, 80 parts of the Radix Paeoniae Albas, 63 parts of Rhizoma Cyperis, 100 parts of Spica Prunellaes, 85 parts of Concha Ostreaes, 85 parts of Radix Salviae Miltiorrhizaes, 22 parts of Scorpios, 68 parts of Radix Scutellariae, 70 parts of Scolopendras, 4 parts of Borneolum Syntheticums, 110 parts of Radix Notoginseng, 18 parts of Endothelium Corneum Gigeriae Galli, 15 parts of Olibanums, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 28 parts of Myrrhas, 102 parts of Herba Solani Lyratis, 50 parts of Herba Hedyotidis Diffusaes, 75 parts of Radix Asparagis, 60 parts of the Radixs Astragali.
Preparation technology of the present invention adopts conventional Chinese medicine preparation technology.
Compared with prior art, this medicament proves to have following advantage through clinical application for many years:
1, therapeutic effect is good: can take effect a general course of treatment of patient (15 days), and effective percentage reaches 80%, and obvious effective rate reaches 90%.
2, pure Chinese medicinal preparation, safe and reliable: the present invention is nontoxic to human body, and is safe and reliable, without any side effects, do not have any sequela.
3, cost is low, is easy to apply: preparation technology of the present invention is conventional Chinese medicine preparation technology, and technology is simple, and the general pharmaceutical factory of traditional Chinese medicine must can not put into production by increase equipment, and production cost is low, is easy to apply, and the patient is acceptant.
The specific embodiment:
Below in conjunction with specific embodiment the present invention is described in detail.
Embodiment 1: a kind of Chinese medicine composition for the treatment of cyclomastopathy, form by following component: Radix Bupleuri 80g, Radix Paeoniae Alba 80g, Rhizoma Cyperi 63g, Spica Prunellae 100g, Concha Ostreae 85g, Radix Salviae Miltiorrhizae 85g, Scorpio 22g, Radix Scutellariae 68g, Scolopendra 70g, Borneolum Syntheticum 4g, Radix Notoginseng 110g, Endothelium Corneum Gigeriae Galli 18g, Olibanum 15g, Rhizoma Atractylodis Macrocephalae 15g, Myrrha 28g, Herba Solani Lyrati 102g, Herba Hedyotidis Diffusae 50g, Radix Asparagi 75g, Radix Astragali 60g.
Embodiment 2: a kind of Chinese medicine composition for the treatment of cyclomastopathy, form by following component: Radix Bupleuri 75g, Radix Paeoniae Alba 95g, Rhizoma Cyperi 60g, Spica Prunellae 110g, Concha Ostreae 80g, Radix Salviae Miltiorrhizae 90g, Scorpio 20g, Radix Scutellariae 70g, Scolopendra 65g, Borneolum Syntheticum 5g, Radix Notoginseng 120g, Endothelium Corneum Gigeriae Galli 18g, Olibanum 18g, Rhizoma Atractylodis Macrocephalae 15g, Myrrha 26g, Herba Solani Lyrati 100g, Herba Hedyotidis Diffusae 60g, Radix Asparagi 40g, Radix Astragali 100g.
Embodiment 3: a kind of Chinese medicine composition for the treatment of cyclomastopathy, form by following component: Radix Bupleuri 90g, Radix Paeoniae Alba 75g, Rhizoma Cyperi 65g, Spica Prunellae 95g, Concha Ostreae 90g, Radix Salviae Miltiorrhizae 80g, Scorpio 18g, Radix Scutellariae 65g, Scolopendra 80g, Borneolum Syntheticum 3g, Radix Notoginseng 100g, Endothelium Corneum Gigeriae Galli 15g, Olibanum 15g, Rhizoma Atractylodis Macrocephalae 18g, Myrrha 30g, Herba Solani Lyrati 95, Herba Hedyotidis Diffusae 50g, Radix Asparagi 75g, Radix Astragali 80g.
In the foregoing description, be most preferred embodiment with embodiment 1.
Claims (2)
1. Chinese medicine composition for the treatment of cyclomastopathy, form by following component: 75～95 parts of Radix Bupleuri, 75～95 parts of the Radix Paeoniae Albas, 55～70 parts of Rhizoma Cyperis, 90～120 parts of Spica Prunellaes, 75～95 parts of Concha Ostreaes, 75～95 parts of Radix Salviae Miltiorrhizaes, 18～25 parts of Scorpios, 60～75 parts of Radix Scutellariae, 60～80 parts of Scolopendras, 3～5 parts of Borneolum Syntheticums, 100～120 parts of Radix Notoginseng, 15～20 parts of Endothelium Corneum Gigeriae Galli, 12～18 parts of Olibanums, 12～18 parts of the Rhizoma Atractylodis Macrocephalaes, 25～32 parts of Myrrhas, 95～110 parts of Herba Solani Lyratis, 50～60 parts of Herba Hedyotidis Diffusaes, 40～75 parts of Radix Asparagis, 60～100 parts of the Radixs Astragali.
2. a kind of Chinese medicine composition for the treatment of cyclomastopathy as claimed in claim 1 is characterized in that: be made up of following component: 80 parts of Radix Bupleuri, 80 parts of the Radix Paeoniae Albas, 63 parts of Rhizoma Cyperis, 100 parts of Spica Prunellaes, 85 parts of Concha Ostreaes, 85 parts of Radix Salviae Miltiorrhizaes, 22 parts of Scorpios, 68 parts of Radix Scutellariae, 70 parts of Scolopendras, 4 parts of Borneolum Syntheticums, 110 parts of Radix Notoginseng, 18 parts of Endothelium Corneum Gigeriae Galli, 15 parts of Olibanums, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 28 parts of Myrrhas, 102 parts of Herba Solani Lyratis, 50 parts of Herba Hedyotidis Diffusaes, 75 parts of Radix Asparagis, 60 parts of the Radixs Astragali.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102194693A CN102091217A (en) | 2009-12-11 | 2009-12-11 | Traditional Chinese medicinal composition for treating hyperplasia of mammary glands |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102194693A CN102091217A (en) | 2009-12-11 | 2009-12-11 | Traditional Chinese medicinal composition for treating hyperplasia of mammary glands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102091217A true CN102091217A (en) | 2011-06-15 |
Family
ID=44124597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102194693A Pending CN102091217A (en) | 2009-12-11 | 2009-12-11 | Traditional Chinese medicinal composition for treating hyperplasia of mammary glands |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102091217A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106266500A (en) * | 2016-08-26 | 2017-01-04 | 宋剑 | A kind of Chinese medicine composition treating cyclomastopathy |
| CN109007996A (en) * | 2018-10-16 | 2018-12-18 | 天津艾安堂生物科技有限公司 | It is a kind of for alleviating the health-care bra of breast disease |
-
2009
- 2009-12-11 CN CN2009102194693A patent/CN102091217A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106266500A (en) * | 2016-08-26 | 2017-01-04 | 宋剑 | A kind of Chinese medicine composition treating cyclomastopathy |
| CN106266500B (en) * | 2016-08-26 | 2019-08-30 | 宋剑 | A kind of Chinese medicine composition for treating the proliferation of mammary gland |
| CN109007996A (en) * | 2018-10-16 | 2018-12-18 | 天津艾安堂生物科技有限公司 | It is a kind of for alleviating the health-care bra of breast disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101152460A (en) | Traditional Chinese medicine for treating puerperal tetanus | |
| CN101129617A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN102626478A (en) | Externally used Chinese herbal medicine compound for treating lumbar muscle strain for years | |
| CN104147502A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of traditional Chinese medicine composition | |
| CN101129503A (en) | Traditional Chinese medicine for treating accumulation-cold headache | |
| CN101337019A (en) | Oral traditional Chinese medicine formulation for treating herpes zoster post herpetic neuralgia and preparation method thereof | |
| CN101357184A (en) | Chinese traditional medicine for treating hepatosis and preparation method thereof | |
| CN102091217A (en) | Traditional Chinese medicinal composition for treating hyperplasia of mammary glands | |
| CN101130053A (en) | Traditional Chinese medicine for treating exogenous injury type blood stasis headache | |
| CN101658636B (en) | Chinese medical composition for treating coronary heart disease | |
| CN1965974A (en) | Medicament for treating psoriasis, preparation process and using method thereof | |
| CN103463460A (en) | Oral traditional Chinese medicine and external application traditional Chinese medicine combined medicine for treating various types of rhinitis | |
| CN100340272C (en) | Headache-treating medicine | |
| CN101199667A (en) | Chinese medicine for treating leukemia, aplastic anemia | |
| CN101112526B (en) | Chinese traditional medicine prescription for treating chloasma administered alternately according to menstrual cycle | |
| CN1204908C (en) | Deafness and tinnitus treating Chinese medicine and its prepn | |
| CN102274409A (en) | Blood pressure lowering Chinese medicinal composition | |
| CN103212036A (en) | Chinese medicament for treating cervical spondylosis | |
| CN102526511B (en) | Chinese medicinal composition for treating hypertension | |
| CN101979073A (en) | Medicament for soothing liver and regulating Qi | |
| CN101129694A (en) | Traditional Chinese medicine for treating muscular contraction headache | |
| CN101658661A (en) | Chinese medicinal composition having effect of promoting blood circulation and removing blood stasis | |
| CN101129554A (en) | Traditional Chinese medicine for treating sick headache | |
| CN101129709A (en) | Traditional Chinese medicine for treating obsolete bone fracture lumbago of the elderly | |
| CN1634471A (en) | Chinese traditional medicine for treating cardiopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110615 |